Agenda

Back
DAY 1
Session II
HER 2+ Breast Cancer, Continued
Friday, September 6, 2024
3:40 pm
—
5:10 pm
Session Moderator(s)

Reshma L. Mahtani, DO

PRESENTATION IN THIS SESSION

Optimal Sequencing of Therapies for HER2+ MBC

Shanu Modi, MD

‍

Audience Q&A

Shanu Modi, MD

‍

Management of Brain Metastates

Manmeet S. Ahluwalia, MD, MBA

‍

Audience Q&A

Manmeet S. Ahluwalia, MD, MBA

‍

Novel/Emerging Treatments for HER2+ MBC

Mark D. Pegram, MD

‍

Audience Q&A

Mark D. Pegram, MD